BIOMAT Database Logo BIOMAT Database Logo

Activation of deoxycytidine kinase by various nucleoside analogues. 1998

T Spasokoukotskaja, and M Sasvári-Székely, and L Hullán, and F Albertioni, and S Eriksson, and M Staub
Semmelweis University of Medicine, Department of Medical Chemistry, Molecular Biology, and Pathobiochemistry, Budapest, Hungary.

The effect of different nucleoside analogues on deoxycytidine kinase (dCK) and thymidine kinase (TK) was compared in normal human lymphocytes and various leukemic cell lines. G-phase enriched tonsilar lymphocyte subpopulation treated by CdA showed more profound stimulation of dCK activity than S-phase cells. No substantial changes in TK activity were detected. CdA treatment increased the activity of dCK 4-fold in peripheral blood mononuclear cells (PBMC) and 2-fold in promyelocytic cell line HL60, too. However, no significant stimulation was detected either in CCRF-CEM or in K562 cell lines. 2-Cl-2'deoxy-2'F-adenine arabinoside (CAFdA), 2F-adenine arabinoside (F-araA) and cytosine arabinoside (AraC) had the same effect as CdA, although higher concentrations were needed for maximal activation. In contrast, treatment by dCyd caused slight inhibition of dCK. The possibility of interference of nucleoside analogues with the mechanisms of posttranslational modification of dCK was proposed.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D003842 Deoxycytidine Kinase An enzyme that catalyzes reversibly the phosphorylation of deoxycytidine with the formation of a nucleoside diphosphate and deoxycytidine monophosphate. Cytosine arabinoside can also act as an acceptor. All natural nucleoside triphosphates, except deoxycytidine triphosphate, can act as donors. The enzyme is induced by some viruses, particularly the herpes simplex virus (HERPESVIRUS HOMINIS). EC 2.7.1.74. Kinase, Deoxycytidine
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077866 Clofarabine An adenine arabinonucleoside derivative that acts as an antineoplastic antimetabolite. It is used in the treatment of ACUTE LYMPHOID LEUKEMIA in pediatric patients who have relapsed. 9H-Purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-,2-Chloro-2'-arabino-fluoro-2'-deoxyadenosine,2-Chloro-2'-fluoroarabino-2'-deoxyadenosine,2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arbinofuranosyl)adenine,2-Chloro-9-(2-deoxy-2-fluoroarabinofuranosyl)adenine,Cl-F-ara-A,Clofarex,Clolar,Evoltra,2 Chloro 2' arabino fluoro 2' deoxyadenosine,2 Chloro 2' fluoroarabino 2' deoxyadenosine
D000227 Adenine Nucleotides Adenine Nucleotide,Adenosine Phosphate,Adenosine Phosphates,Nucleotide, Adenine,Nucleotides, Adenine,Phosphate, Adenosine,Phosphates, Adenosine

Related Publications

T Spasokoukotskaja, and M Sasvári-Székely, and L Hullán, and F Albertioni, and S Eriksson, and M Staub
Phosphorylation of 5-halogenated deoxycytidine analogues by deoxycytidine kinase.
November 1973, Molecular pharmacology,
T Spasokoukotskaja, and M Sasvári-Székely, and L Hullán, and F Albertioni, and S Eriksson, and M Staub
Synthesis of new fluorescent nucleoside analogues and application to the study of human deoxycytidine kinase.
January 1999, Nucleosides & nucleotides,
T Spasokoukotskaja, and M Sasvári-Székely, and L Hullán, and F Albertioni, and S Eriksson, and M Staub
Structural basis for activation of the therapeutic L-nucleoside analogs 3TC and troxacitabine by human deoxycytidine kinase.
January 2007, Nucleic acids research,
T Spasokoukotskaja, and M Sasvári-Székely, and L Hullán, and F Albertioni, and S Eriksson, and M Staub
Redesigning human 2'-deoxycytidine kinase enantioselectivity for L-nucleoside analogues as reporters in positron emission tomography.
October 2014, ACS chemical biology,
T Spasokoukotskaja, and M Sasvári-Székely, and L Hullán, and F Albertioni, and S Eriksson, and M Staub
T-lymphoblast-specific nucleoside kinase: characterization and comparison with deoxycytidine kinase.
January 1985, The International journal of biochemistry,
T Spasokoukotskaja, and M Sasvári-Székely, and L Hullán, and F Albertioni, and S Eriksson, and M Staub
Lipophilic Triphosphate Prodrugs of Various Nucleoside Analogues.
July 2020, Journal of medicinal chemistry,
T Spasokoukotskaja, and M Sasvári-Székely, and L Hullán, and F Albertioni, and S Eriksson, and M Staub
Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes.
February 2003, Biochemical pharmacology,
T Spasokoukotskaja, and M Sasvári-Székely, and L Hullán, and F Albertioni, and S Eriksson, and M Staub
Inhibition of nucleoside diphosphate kinase (NDPK/nm23) by cAMP analogues.
January 1997, FEBS letters,
T Spasokoukotskaja, and M Sasvári-Székely, and L Hullán, and F Albertioni, and S Eriksson, and M Staub
Nucleoside triphosphate donors for nucleoside kinases: donor properties of UTP with human deoxycytidine kinase.
November 1995, Biochemical and biophysical research communications,
T Spasokoukotskaja, and M Sasvári-Székely, and L Hullán, and F Albertioni, and S Eriksson, and M Staub
Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells.
January 1987, Acta biochimica Polonica,
Copied contents to your clipboard!